Patent details

Basic Information

Publication number:

EP2694037

PCT Application Number:

PCT/US/2012/031340

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP127141638

PCT Publication Number:

WO/2012/135561

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FORMULATIONS COMPRISING 2-AMINO-2-Ö2-(4-OCTYLPHENYL)ETHYLÜPROPANE-1,3-DIOL

French Title of Invention:

FORMULATIONS COMPRENANT 2-AMINO-2-Ö2-(4-OCTYLPHENYL)ETHYLÜPROPANE-1,3-DIOL

German Title of Invention:

FORMULIERUNGEN ENTHALTEND 2-AMINO-2-Ö2-(4-OCTYLPHENYL)ETHYLÜPROPAN-1,3-DIOL

SPC Number:

Dates

Filing date:

30/03/2012

Grant date:

12/10/2016

EP Publication Date:

12/10/2016

PCT Publication Date:

04/10/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/02/2014

EP B1 Publication Date:

12/10/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

30/03/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/03/2012

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:

RANE Supriya

Address:

United States (US)

Priority

1

Priority Number:

201161470747

Priority Date:

01/04/2011

Priority Country:

United States (US)

2

Priority Number:

201161545835

Priority Date:

11/10/2011

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/137;

Annual Fees

Annual Fee Due Date:

31/03/2027

Annual Fee Number:

16

Annual Fee Amount:

230 Euro

Expected Payer:

Last Annual Fee Payment Date:

16/03/2026

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages